The Frequent Unusual Headache Syndromes: A Proposed Classification Based on Lifetime Prevalence

Headache
Marcelo M Valença, Daniella A de Oliveira

Abstract

There is no agreement on a single cutoff point or prevalence for regarding a given disease as rare. The concept of what is a rare headache disorder is even less clear and the spectrum from a very frequent, frequent, occasional to rare headache syndrome is yet to be established. An attempt has been made to estimate the lifetime prevalence of each of the headache subtypes classified in the ICHD-II. Using the ICHD-II, 199 different headache subtypes were identified. The following classification was made according to the estimated lifetime prevalence of each headache disorder: very frequent (prevalence >10%); frequent (between 1 and 10%); occasional (between 0.07 and 1%); and unusual or rare (<0.07%). One hundred and fifty-four of 199 (77%) were categorized as unusual headache disorders, 7/199 (4%) as very frequent, 9/199 (5%) as frequent, and 29/199 (15%) as occasional forms of headache disorder. The unusual headache syndromes do not appear to be as infrequent in clinical practice as has been generally believed. About three-fourths of the classified headache disorders found in the ICHD-II can be considered as rare. This narrative review article may be regarded as an introduction to the concept of unusual headaches and a proposed c...Continue Reading

References

Nov 1, 1976·Headache·N H Raskin, S C Knittle
Jun 1, 1992·Neurology·B K Rasmussen, J Olesen
Nov 1, 1991·Headache·P JauslinJ W Lance
Apr 1, 1971·Journal of Neurology, Neurosurgery, and Psychiatry·W E Waters, P J O'Connor
Apr 1, 1970·Headache·T Dalsgaard-Nielsen
Apr 1, 1993·Cephalalgia : an International Journal of Headache·W F Stewart, R B Lipton
May 1, 1996·Headache·W L SanvitoR J Leme
May 1, 1996·Neurologic Clinics·S D Silberstein, R B Lipton
Nov 14, 1997·Cephalalgia : an International Journal of Headache·M B Russell
Dec 17, 1997·Cephalalgia : an International Journal of Headache·P M Lavados, E Tenhamm
Feb 12, 1998·JAMA : the Journal of the American Medical Association·B S SchwartzR B Lipton
May 22, 1998·Cephalalgia : an International Journal of Headache·D W DodickJ K Campbell
Oct 30, 1998·Cephalalgia : an International Journal of Headache·V GuidettiS Trillo
Nov 25, 1998·Cephalalgia : an International Journal of Headache·P M Lavados, E Tenhamm
Jan 16, 1999·Emergency Medicine Clinics of North America·M Sztajnkrycer, E C Jauch
Sep 1, 1999·International Clinical Psychopharmacology·D MarazzitiG B Cassano
Apr 12, 2000·Headache·J Bánk, S Márton
Apr 12, 2000·Headache·K NegoroH Nogaki
Apr 11, 2001·Neurology·N Breslau, B K Rasmussen
Jul 10, 2001·Cephalalgia : an International Journal of Headache·O SjaastadL S Bakketeig
Aug 2, 2001·The Medical Clinics of North America·L K Mannix
Oct 26, 2001·Current Pain and Headache Reports·J PascualJ Castillo
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·D W Dodick
Mar 21, 2002·Acta Neurologica Scandinavica·O SjaastadL S Bakketeig
Jul 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·N Giffin
Dec 17, 2002·Headache·Stefanie FörderreutherAndreas Straube
Dec 18, 2002·Cephalalgia : an International Journal of Headache·O Sjaastad, L S Bakketeig
Dec 21, 2002·BMJ : British Medical Journal·Maya KaczorowskiUNKNOWN Ice cream evoked headaches
Feb 14, 2003·Current Neurology and Neuroscience Reports·Shuu-Jiun Wang
Feb 27, 2003·Cephalalgia : an International Journal of Headache·H F BoardmanD S Millson
Mar 12, 2003·Current Pain and Headache Reports·Alan G Finkel
Sep 3, 2003·Cephalalgia : an International Journal of Headache·O Sjaastad, L S Bakketeig
Sep 27, 2003·Cephalalgia : an International Journal of Headache·B Müngen, S Bulut
Sep 27, 2003·Headache·R Michael Gallagher, Loretta Mueller
Nov 8, 2003·Current Pain and Headache Reports·Rigmor Jensen
Feb 27, 2004·Cephalalgia : an International Journal of Headache·Jong-Ling FuhKai-Dih Juang
Feb 27, 2004·Current Neurology and Neuroscience Reports·Marcelo E BigalWalter F Stewart
Mar 12, 2004·Headache·Marcelo M ValençaJosé G Speciali
Apr 22, 2004·Lancet Neurology·Michael Bjørn Russell
Nov 19, 2004·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G CasucciP Torelli
Dec 21, 2004·Cephalalgia : an International Journal of Headache·P D Drummond, A Granston
Mar 19, 2005·Cephalalgia : an International Journal of Headache·O SjaastadL S Bakketeig
Apr 22, 2005·The American Journal of Medicine·Richard B Lipton, Marcelo E Bigal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Research and Clinical Studies in Headache
A Lunedei
Aǧrı : Ağrı (Algoloji) Derneği'nin Yayın organıdır = The journal of the Turkish Society of Algology
Vesile Oztürk
© 2021 Meta ULC. All rights reserved